Triangle Insights hires Aileen Nicoletti and Michael Turner as partners
Triangle Insights Group, a Durham, NC-based life sciences consulting firm, has hired Aileen Nicoletti, PhD, and Michael Turner as partners.
Based in Denver, Nicoletti has over two decades of experience advising biotech and pharma clients on portfolio and commercialization strategy, with expertise across new product planning, portfolio management, and brand and launch strategy.
Nicoletti was previously a senior principal at CEEK Enterprises, a VP at Charles River Associates, and a VP at Defined Health.
She has a bachelor’s degree in chemistry from the College of William and Mary and a PhD in biochemistry from the University of Michigan.
Based in New York, Turner has over 25 years of experience of commercial strategy consulting experience in life sciences. He has advised biopharma firms on new product planning and go-to-market strategy, commercial and competitive strategy, and portfolio strategy.
Turner was previously a partner at LifeSci Consulting, Blue Fin Group, and PA Consulting. Earlier in his career, Turner was a managing director at Inventiv Health and a director at MarketRx. Before entering life sciences consulting, he was a financial examiner at the Federal Reserve Bank of New York.
Turner has a bachelor’s degree in operations research and engineering from Cornell University and an MBA from the University of Michigan.
“The addition of Aileen and Michael further strengthens the Triangle and Mercalis leadership teams," said Chris Apolito, founding partner of Triangle Insights Group. "For many years, both individuals have demonstrated excellence in their fields and are very highly respected in the world of life sciences consulting. I look forward to the many contributions they will make going forward."
Triangle Insights is part of Mercalis (formerly TrialCard), a Morrisville, NC-based life sciences commercialization firm that acquired it in April 2022.
Triangle Insights was founded in 2013 and provides services in pricing and market access; marketing, commercialization, and sales; and corporate and business development.